The present technology is generally related to cryoablation probe assemblies and methods of conducting cryoablation procedures that can be used to treat, for example, heart arrhythmias. The present technology is more specifically related to cryoablation probe assemblies that, for example, use heated fluid (e.g., saline) for thawing and detachment of a cryoablation probe from treated epicardial tissue.
Atrial fibrillation is a type of heart arrhythmia or irregular heartbeat. In some circumstances, atrial fibrillation causes a decrease in the efficiency of the heart. In some circumstances, atrial fibrillation poses no immediate threat to the health of the individual suffering from the condition, but may, over time, result in conditions adverse to the health of the patient, including heart failure and stroke.
A variety of cardiac ablation devices and methods are currently available to treat atrial fibrillation and other arrhythmias. With some systems, endocardial tissue is contacted and ablated, for example via a cryoablation instrument via a standard sternotomy. Once the cryoablation instrument is positioned, cardiac tissue is frozen through cryogenic mechanism(s). Freezing destroys the treated tissue and helps to restore normal electrical conduction in the heart and to eliminate or reduce the arrhythmia.
The techniques described and otherwise disclosed generally relate to devices and methods for cryoablation procedures. Such devices and methods allow for a speedy detachment of a cryoablation probe from treated epicardial tissue and/or endocardial tissue by warming the tissue, for example, with fluid. Because several cryo-based lesions are typically completed per procedure, minimizing the overall cycle time is believed to provide significant efficiencies in the operating theater and reduces patient risk by reducing the overall procedure time.
One example provides a cryoablation probe assembly including a handle and a cryoablation probe supported by the handle. The assembly further includes a sheath coaxially positioned around the cryoablation probe. The sheath has a body defining a distal face, a central lumen and a plurality of channels extending from the distal face and through the body of the sheath. In addition, the assembly includes a fluid port in communication with the plurality of channels of the sheath. In some examples, a fluid source is connected to the fluid port. Optionally, the fluid source is in fluid communication with the central lumen. In some examples, the sheath is configured to slide with respect to the cryoablation probe.
Another example provides methods of conducting a cardiac cryoablation procedure. Such methods can include providing a cryoablation probe assembly including a handle and a cryoablation probe supported by the handle. The cryoablation probe including a bellows section including a first end and a second end. The assembly also includes a sheath coaxially positioned around the cryoablation probe. The sheath including a body defining a distal face, a central lumen and a plurality of channels extending from the distal face and through the body of the sheath. The assembly further includes a fluid port in communication with the plurality of channels of the sheath. The method includes positioning the bellows section of the cryoablation probe on cardiac tissue at a first location and freezing cardiac tissue at the first location to create a first transmural lesion. Additionally, the method includes directing fluid through the plurality of channels and through the distal face to the first end of the bellows section to release the first end of the bellows section from the cardiac tissue. The method further includes distally advancing the sheath and directing fluid through one or more of the plurality of channels or a central lumen of the sheath until the second end of the bellows is released from the cardiac tissue. The steps of forming lesions and freeing the cryoablation probe from frozen tissue can be repeated, as desired.
The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.
Specific embodiments of the present disclosure are now described with reference to the figures, wherein like reference numbers indicate identical or functionally similar elements. The terms “distal” and “proximal” are used in the following description with respect to a position or direction relative to the treating clinician. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician.
One illustrative example of a cryoablation probe assembly 10 of the disclosure is shown in
Therefore, the assembly 10 additionally includes a sheath 20 configured to accelerate thawing and detachment of the cryoablation probe 12 from the tissue. The sheath 20 has a fluid port 22 and is coaxially positioned around the body 14 and covers a portion of a length of the body 14 between the bellows section 16 and the handle 18. In some examples, the sheath 20 can slide with respect to both the cryoablation probe 12 and the handle 18. In the illustrated example, the sheath 20 passes through the ends 18a, 18b of the handle 18 to slide and position a distal face 34 of the sheath 20 at various positions along a length of the body 14 of the cryoablation probe 12. The sheath 20 includes a body 24 and, optionally, a plurality of channels 26 extending through the body 24, each terminating at an opening 28 on the distal face 34. The sheath 20 further includes a central lumen 32 positioned within and defined by the body 14 for receiving the cryoablation probe 12. The central lumen 32 terminating at the distal face 34. Saline or the like can be directed from a fluid source (schematically shown as “FS”), though the fluid port 22, along the channels 26 and out of the openings 28 to dispense the saline (e.g., 0.9% normal saline) or other sterile biocompatible fluid (e.g., sterile water, sterile air, etc.) at the distal face 34, adjacent the bellows section 16. In this way, cardiac tissue adjacent the distal face 34 can be quickly thawed after being ablated so that the cryoablation probe 12 can be readily removed from the tissue for conducting an additional ablation or completion of the procedure. Because the sheath 20 can slide along the body 14 of the cryoablation probe 12, fluid can be continually dispersed to directionally thaw the tissue first from the first end 16a of the bellows section 16 and then to the distal end 16b of the bellows section 16 as fluid is dispersed and tissue thaws. In another example, the fluid port 22 can alternatively or additionally be fluidly connected to the central lumen 32 so that fluid can be directed though central lumen 32 to exit at the distal face 34 to directionally thaw tissue in a similar manner. In other words, as a proximal area of the tissue thaws, the sheath 20 at the distal face 34 can be distally advanced over the recently thawed tissue to further the thawing process. If not saline, any other biocompatible fluid can be used with the devices and methods of the disclosure.
The channels 26 can take many configurations to achieve the goal of dispensing thawing fluid around the circumference of the cryoablation probe 12. Generally, the sheath 20 includes at least four channels 26. In some examples, the plurality of channels 26 collectively span 360 degrees of the distal face 34. Optionally, the opening 28 of each of the plurality of channels 26 at the distal face 34 are equally spaced.
Referring in addition to
In some instances, frost builds up, for example, on the bellows section 16. This frost build up is more likely to occur after consecutive ablative procedures. When frost build does occur, it becomes difficult for the sheath 20 to slide with respect to both the cryoablation probe 12 and the handle 18. When the build-up of frost occurs on the bellows section 16, the sheath 20 may not slide between the cryoablation probe 12 and the handle 18 (e.g., the sheath 20 is frozen in place). In some instances, the distal face 34 and the openings 28 also experience build-up of frost. When this occurs, the fluid F supplied from the channels 26 is blocked from exiting the openings 28.
To help reduce problems caused by frost build-up, some examples include heating elements. One example is shown in
In the illustrated example, the electrical heating element 36 is a resistive heating element (e.g., a resistive heating coil that includes one or more loops). The electrical heating element 36 receives a current from a control unit (further described below with reference to
In other examples, the electrical heating element 36 is an inductive heating element (e.g., an inductive heating coil that includes one or more loops). An external electro-magnetic field generator creates an external electro-magnetic field . The external electromagnetic field induces currents inside the electrical heating element 36, for example, eddy currents. The eddy currents flow through the electrical heating element 36 and the electrical heating element 36 converts electrical energy of the currents to heat via Joule heating. The heat radiates through the sheath 20 to thaw the build-up of frost on the distal face 34 and the openings 28.
As an alternative to resistive and inductive heating elements in the sheath 20, some examples use external sources to provide heat to thaw tissue. In some instances, heating energy is applied using radio frequency heating, microwave heating, or ultrasonic heating from a suitable source, for example a radio frequency heating system, a microwave generator, or an ultrasonic heating system.
In some examples, the sheath 20 includes a thermally insulating material or layer located between the central lumen 32 and the outer layer OL. This insulating material or layer helps to maintain heat generated by the electrical heating element 36 in the sheath 20 and reduce heating of the outer layer OL. In some cases, the channels 26 act as the thermally insulating material. Typically, saline is directed through the channels 26. However, the insulating capability of the channels 26 is increased when sterile biocompatible fluid such as sterile air is directed from the fluid source FS through the channels 26.
In some examples, the cryoablation probe 12 includes a temperature sensor 37 at a distal tip of the body 14. The temperature sensor 37 is configured to sense a temperature of the body 14. When the cryoablation probe 12 is in use it contacts the patient's tissue and, therefore, the temperature sensor 37 provides an indication of the temperature of the tissue. The temperature sensor 37 is also configured to transmit a signal indicative of the temperature to the control unit.
In the example illustrated, the plurality of holes 40 are laser drilled into the fluid tube 38. Laser drilling is a preferred technique of creating the plurality of holes 40 because it is possible with laser drilling to create holes at a size small enough to evenly supply fluid F along the length L of the sheath 20. It is, however, possible to create the holes 40 using techniques other than laser drilling.
The fluid tube 38 also includes an end portion 42. The end portion 42 is positioned proximate the first end 16a of the bellows section 16. The end portion 42 supplies the fluid F to thaw the bellows section 16 and a portion of sheath 20 located near the first end 16a. Thawing the bellows section 16 aids in sliding the sheath 20 along the bellows section 16. The plurality of holes 40 and the end portion 42 direct the fluid F into the inner area IA of the sheath 20 and around the central lumen 32 to the first end 16a of the bellows section 16. The fluid F aids in releasing the first end 16a of the bellows section 16 from the cardiac tissue.
With reference to
It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
Number | Date | Country | |
---|---|---|---|
63338180 | May 2022 | US |